{
  "query": "adverse irritability subgroup analyses",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT01262872",
          "briefTitle": "Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-02-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-03-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Infections, Streptococcal"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1320,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "56 Days",
          "maximumAge": "4 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01001169",
          "briefTitle": "Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-10-01"
          },
          "completionDateStruct": {
            "date": "2010-05-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Influenza"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04195256",
          "briefTitle": "Intranasal Dexmedetomidine Plus Ketamine for Procedural Sedation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Fracture", "Dislocation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 400,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01310413",
          "briefTitle": "Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-03-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2014-01-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Influenza", "Influenza Vaccines"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 842,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01323946",
          "briefTitle": "Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-04-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2012-11-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Influenza"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 113,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "35 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03781167",
          "briefTitle": "A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-04-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-08-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Parkinson's Disease (PD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 244,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "30 Years"
        }
      }
    ]
  }
}
